Rodriguez Susan
SEC-identified person · CIK 1812511 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Veradigm Inc. mdrx | Director | filed 2023 - 2026 |
| Monopar Therapeutics MNPR | CCSO | filed 2026 - 2026 |
| Flamel Technologies SA FLML | Chief Operating Officer | filed 2025 - 2026 |
| Heron Therapeutics, INC. /DE/ appa | Director | filed 2021 - 2025 |
| Ardelyx, INC. ARDX | Chief Commercial Officer | filed 2020 - 2024 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.